StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.85−0.38 (-11.61%)

Close on Nov 17, 2026Market cap $234.24MP/E –Yield –

Lexeo Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Lexeo Therapeutics's profit margin for the twelve months ending Dec 31, 2022 was -9063.8%. For fiscal 2022 it was -9063.8%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-9063.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2022Sep 30, 2022-3211.9%–

More Lexeo Therapeutics figures

See a number that looks wrong?